Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)

Gabriel Rinnerthaler; Simon Peter Gampenrieder; D Voskova; A Petzer; M Hubalek; E Petru; B Hartmann; J Andel; M Balic; Thomas Melchardt; H Ulmer; Brigitte Mlineritsch; Richard Greil

doi:10.1158/1538-7445.SABCS16-P5-15-13

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)

Gabriel Rinnerthaler, Simon Peter Gampenrieder, D Voskova, A Petzer, M Hubalek, E Petru, B Hartmann, J Andel, M Balic, Thomas Melchardt, H Ulmer, Brigitte Mlineritsch, Richard Greil

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	77
DOIs	https://doi.org/10.1158/1538-7445.SABCS16-P5-15-13
Publication status	Published - 2017
Event	San Antonio Breast Cancer Symposium - San Antonio, TX Duration: 6 Dec 2016 → 10 Dec 2016

Access to Document

10.1158/1538-7445.SABCS16-P5-15-13

Cite this

Rinnerthaler, G., Gampenrieder, S. P., Voskova, D., Petzer, A., Hubalek, M., Petru, E., Hartmann, B., Andel, J., Balic, M., Melchardt, T., Ulmer, H., Mlineritsch, B., & Greil, R. (2017). Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6). CANCER RESEARCH , 77. https://doi.org/10.1158/1538-7445.SABCS16-P5-15-13

Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter ; Voskova, D et al. / Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6). In: CANCER RESEARCH 2017 ; Vol. 77.

@article{083a6670a3bd482ea2391cc7f5cf9f84,

title = "Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)",

author = "Gabriel Rinnerthaler and Gampenrieder, {Simon Peter} and D Voskova and A Petzer and M Hubalek and E Petru and B Hartmann and J Andel and M Balic and Thomas Melchardt and H Ulmer and Brigitte Mlineritsch and Richard Greil",

year = "2017",

doi = "10.1158/1538-7445.SABCS16-P5-15-13",

language = "English",

volume = "77",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

note = "San Antonio Breast Cancer Symposium ; Conference date: 06-12-2016 Through 10-12-2016",

}

Rinnerthaler, G , Gampenrieder, SP, Voskova, D, Petzer, A, Hubalek, M, Petru, E, Hartmann, B, Andel, J, Balic, M, Melchardt, T, Ulmer, H, Mlineritsch, B & Greil, R 2017, 'Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)', CANCER RESEARCH , vol. 77. https://doi.org/10.1158/1538-7445.SABCS16-P5-15-13

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6). / Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter; Voskova, D et al.
In: CANCER RESEARCH , Vol. 77, 2017.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)

AU - Rinnerthaler, Gabriel

AU - Gampenrieder, Simon Peter

AU - Voskova, D

AU - Petzer, A

AU - Hubalek, M

AU - Petru, E

AU - Hartmann, B

AU - Andel, J

AU - Balic, M

AU - Melchardt, Thomas

AU - Ulmer, H

AU - Mlineritsch, Brigitte

AU - Greil, Richard

PY - 2017

Y1 - 2017

U2 - 10.1158/1538-7445.SABCS16-P5-15-13

DO - 10.1158/1538-7445.SABCS16-P5-15-13

M3 - Abstract (Journal)

SN - 0008-5472

VL - 77

JO - CANCER RESEARCH

JF - CANCER RESEARCH

T2 - San Antonio Breast Cancer Symposium

Y2 - 6 December 2016 through 10 December 2016

ER -

Rinnerthaler G , Gampenrieder SP, Voskova D, Petzer A, Hubalek M, Petru E et al. Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6). CANCER RESEARCH . 2017;77. doi: 10.1158/1538-7445.SABCS16-P5-15-13